Characterization and Prediction of Atrial Fibrillation-caused Adverse Events After Hospital Discharge for Cardiac Surgery

NCT03466125 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 25000

Last updated 2023-02-08

No results posted yet for this study

Summary

The purpose of the research is to identify the frequency and severity of adverse events related to atrial fibrillation that occur after discharge from hospital where the patient underwent cardiac surgery.

The Specific Aims of the proposed study are to:

1. Identify the predictors of postoperative atrial fibrillation after discharge from hospital.
2. Identify the frequency of readmission to hospital, or other resource use such as Emergency Department or outpatient visit, for the treatment or prophylaxis of postoperative AF and consequent stroke or bleeding outcomes.
3. Identify the risks for stroke, death and other morbidity in patients after cardiac surgery and the effect of postoperative AF upon subsequent stroke or bleeding outcomes.

Conditions

Interventions

PROCEDURE

Cardiac surgery

Retrospective cohort study

Sponsors & Collaborators

  • Beth Israel Deaconess Medical Center

    collaborator OTHER
  • Massachusetts General Hospital

    collaborator OTHER
  • Baystate Medical Center

    collaborator OTHER
  • Cape Cod Hospital

    collaborator OTHER
  • Mount Auburn Hospital

    collaborator OTHER
  • Memorial University Medical Center

    collaborator OTHER
  • Tufts Medical Center

    collaborator OTHER
  • St. Elizabeth's Medical Center

    collaborator UNKNOWN
  • SouthCoast Medical Group

    collaborator OTHER
  • Brigham and Women's Hospital

    lead OTHER

Principal Investigators

  • Jochen D Muehlschlegel, MD, MMSc · Brigham and Women's Hospital

Eligibility

Min Age
20 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03466125 on ClinicalTrials.gov